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The study aimed at detecting apoptotic endothelial cells (ECs) and smooth muscle cells (SMCs) together with determining
expression of NF-kappaB (p105/p50) and Bax in varicose vein walls. Women (n = 35) undergoing the excision of varicose veins
were divided into 3 groups: younger than 35 years (I), 36–50 years (II), and older than 50 years (III). Apoptosis was determined by
theTUNELmethod,NF-kappaBandBaxexpressionbyimmunohistochemistry.ThepercentageofapoptoticECsandSMCsinthe
layers of varicose vein wall increased in groups II and III. NF-kappaB expression had the lowest level in Group II with particularly
low level in the media. Contrariwise, Bax expression levels in Group II were increased. The study revealed that in varicose veins
ECs and SMCs apoptosis increased with advancing age. If increase in apoptosis during earlier stages of varicosities is probably
regulated by intrinsic pathway, then in older patients other signaling pathways may be involved.
1.Introduction
Varicose veins of legs are one of the commonest diseases
aﬀecting people worldwide. However, despite extensive stud-
ies, the etiology of varicose veins is still unclear as well
as molecular mechanisms that could potentially lead to
the dilation of the vein wall. Defects in the cellular and
extracellularmatrixcompositionoftheveinwallarebelieved
to cause weakness and alter venous tone, resulting in the
formation of varicose veins [1]. Dysfunctional endothelial
cells (ECs) and smooth muscle cells (SMCs) are probably
the crucial regulators in the cascade of events leading
to the restructuring of the vein wall with consequent
venous dilatation. The endothelium regulates venous tone
through release of vasoactive substances constricting and
relaxing the veins. Both reduction of factors contributing
to vasoconstriction and upregulation of factors contributing
to vasodilatation have been shown in varicose veins [2–
4]. Previously we have also shown that ECs of varicose
veins appear desquamated and degenerated under electron
microscopy [5]. As reported by Wali and Eid [6, 7], damaged
ECs stimulate the recruitment of leukocytes and the release
of growth factors, causing SMC hypertrophy, proliferation,
and migration into the intima. Hypertrophy of SMCs in the
media of varicose veins has also been described by Lee et al.
[8]. One of the factors which can alter vein wall structure is
dysregulated apoptosis. This may cause dediﬀerentiation of
SMCs, transforming them from a contractile to a secretory
type leading to the irregular ﬁbrotic nature of the varicose
vein wall [9]. Concerning the role of SMC apoptosis
in varicose veins, controversial data have been obtained.
Several authors [10–12] have reported reduction of the
number of apoptotic SMCs in varicose veins compared with
nonvaricose veins. Contrariwise, Bujan and co-authors [13]
have found an increase of apoptotic SMCs in varicose veins.
Urbanek and coauthors [14] have described an increase of
the apoptotic index in the media of varicose veins of patients
younger than 50 years, but not in the older age group. On
the other hand, much less attention has been paid to the
apoptotic regulation of endothelial cells in varicose veins.
Apoptotic dysregulation in varicose veins is shown to be
mediated via the intrinsic pathway. Ducasse and coauthors2 International Journal of Vascular Medicine
[10] have immunohistochemically quantiﬁed fewer Bax,
and caspase-9-positive cells in the wall of varicose veins
compared to healthy veins, but no changes were detected
in Fas and caspase 8 immunoreactivity. Lee with co-authors
[8, 19] have found dysregulation of apoptosis through the
intrinsic pathway in the varicose veins and in the internal
spermatic veins of patients with varicosele, which allows
the authors to speculate that the mechanism of reduced
apoptosismightcontributetothedilatedandthickenedwalls
of both venous diseases.
Expression levels of apoptotic proteins have been re-
ported to be upregulated by the nuclear transcription factor
kappaB(NF-kappaB)which,besidebeingacentralregulator
of the innate and adaptive immune response, is commonly
described as an antiapoptotic transcription factor [16, 17],
although under certain circumstances NF-kappaB might
also positively contribute to apoptosis induction [20–22].
Many common diseases (cancer, atherosclerosis, diabetes)
are also associated with the dysregulation of NF-kappaB
signaling pathways that control its activity. Dysregulation of
apoptosis, dependent on NF-kappaB activity, may also play
an important role in the development of varicosities.
In our study we focused on the changes of the expression
of molecular mediators NF-kappaB and Bax in the diﬀerent
layers of varicose vein walls in women of diﬀerent age groups
and attempted to associate it with the changes in the number
of apoptotic ECs and SMCs.
2.MaterialsandMethods
2.1. Patients and Samples. Samples from great saphenous
veins of 35 female patients undergoing surgery for varicosi-
ties were studied. The patients were divided into groups
according to their age: Group I (younger than 35 years),
Group II (36–50 years), and Group III (older than 50 years).
More details about the groups and patients are given in
Table 1.
The protocol for the research project has been approved
by the Ethics Review Committee on the Human Research
of the University of Tartu, and it is in accordance with
the Declaration of Helsinki (1964). Informed consent was
obtained from each patient.
The patients were operated at the Surgery Clinic, the
University of Tartu, Estonia.
Patients with any concomitant disease were excluded
from the study. Among patients investigated by us, there
were three women with overweight and one woman who
smoked. In our patients hormonal replacement therapy was
not recorded, but 70% of the patients reported varicose veins
in their parents.
Vein specimens were ﬁxed in 10% buﬀered formalin,
embedded in paraﬃn, and cut into sections of four microm-
eter thickness.
2.2. Detection of Apoptosis. The paraﬃns e c t i o n sw e r e
dewaxed and rehydrated, and the in situ cell death detection
kit, Fluorescein (Roche Diagnostics GmbH, Mannheim,
Germany) was used for the detection of apoptotic cells
according to the manufacturer’s protocol as described
earlier [23, 24] .T h es e c t i o n sw e r ep e r m e a b i l i z e dw i t h
proteinase K, PCR grade (Roche Diagnostics GmbH,
Mannheim, Germany) and washed with phosphate-buﬀered
saline (PBS), pH 7.4. The apoptotic cells were determined
by terminal deoxynucleotidyl transferase-(TdT-) mediated
deoxyuridinetriphosphate-(dUTP-) ﬂuorescein nick end
labelling of the free 3 -OH DNA terminal of fragmented
DNA present in the apoptotic cells (TUNEL). For negative
controls sections were incubated with solution without
terminal transferase.
Apoptotic nuclei appeared to be green, whereas nuclei
without strand breaks were not labelled. The apoptotic cells
were counted with the microscope Zeiss Axiophot 2 in UV
light, using a ×40 objective. Apoptotic index was calculated
as percentage of TUNEL-positive cells by the following
equation: apoptotic cells % = (number of TUNEL-positive
cells/total number of cells) × 100.
2.3. Immunohistochemical Investigations. The localisation of
NF-kappaB and Bax was determined in the endothelium, the
subendothelial layer, the media, and the adventitia immuno-
histochemically, using the NF-kappaB p105/p50 antibody
(ab7971, Abcam, Cambridge, UK) and the rabbit polyclonal
antibody to Bax (ab16837, Abcam, Cambridge, UK). The
staining procedure was continued with the Vectastain R
Universal Elite ABC Kit (Vector Laboratories, Burlingame,
Calif USA). In brief, the protocol combined the follow-
ing steps. Four-μm-thick paraﬃn sections were dewaxed,
rehydrated, and washed for 5 minutes in PBS, pH 7.4.
Endogenousperoxidaseactivitywasblockedby3%hydrogen
peroxide (H2O2) solution incubating the sections for 30
minutesin ahumidiﬁed chamber,thenwashedwithPBSand
incubated with a diluted normal blocking serum prepared
from the same species in which the secondary antibody was
produced. After that the sections were incubated with the
primary antibody in dilutions 1:30 (NF-kappaB) and 1:50
(Bax) overnight. The sections were washed with PBS and
incubated with a diluted biotinylated secondary antibody
solution for 45 minutes at room temperature. Then the
sections were rinsed with PBS and incubated for 30 minutes
at room temperature with Vectastain Elite ABC Reagent
and with 3,3 -diaminobenzidine (DAB)+Chromogen (Dako
Cytomation, Carpinteria, Calif, USA) for 10–15 minutes and
counterstained with Harris’ haematoxylin. Immunostaining
negative controls were performed by omitting primary
antibody.
The intensities of the expressions of NF-kappaB and
Bax were estimated visually with a light microscope using
×40 objective, and the staining intensity was graded from
+ (minimum) to ++++ (maximum) by two independent
observersinablindfashion.Iftheresultsofthetwoobservers
were not matching, the discordant cases were reevaluated by
the two observers together.
2.4. Statistical Analysis. T h ed a t aw e r ea n a l y z e da n dp r e -
sented as mean ± SEM. Statistical analyses were conducted
by the ANOVA (count of apoptotic endothelial and smooth
muscle cells) and the Mann-Whitney U test (evaluation ofInternational Journal of Vascular Medicine 3
Table 1: Groups of patients and their characteristics.
Group Age No. of patients CEAP classiﬁcation∗
I Younger than 35 years (mean age 31 years) 8 C2 (n = 6); C3 (n = 2)
II Age between 36–50 years (mean age 42 years) 11 C2 (n = 9); C3 (n = 2)
III Older than 50 years (mean age 59 years) 16 C2 (n = 12); C4 (n = 4)
∗CEAP classiﬁcation: classiﬁcation system of varicose veins accounting clinical, etiological, anatomical, and pathophysiological aspects.
the immunohistochemical staining of Bax and NF-kappaB).
Statistical signiﬁcance was accepted when P<0.05.
3. Results
Results of the evaluation of NF-kappaB (p105/p50) immun-
ostaining intensity in the walls of varicose veins of women
of diﬀerent age groups are summarized in Figure 1.O u r
investigations showed that the p105/p50 expression was at
the lowest level in Group II in all layers of the vein wall as
compared to Groups I and III. When comparing layers of the
vein wall, the highest p105/p50 expression was seen in the
adventitiaandthelowestinthemedia(Figure 1).Particularly
in Group II the expression of p105/p50 in the media was
absent in some cases or had a low grade (Figure 2(a)). On
the contrary, in Groups I and III p105/p50 levels were higher
in all layers of the vein wall (Figure 2(b)).
Two regulatory pathways of apoptosis are recognised.
The intrinsic pathway (mitochondria pathway) and the
extrinsic pathway (transmembrane pathway) are induced by
various cellular and external stimuli and are regulated by the
activation of diﬀerent caspases [15]. The intrinsic pathway
of apoptosis occurs as a consequence of mitochondrial per-
meabilization and is regulated by proapoptotic proteins such
as Bcl-2-associated protein x (Bax), and it involves speciﬁc
caspases,especiallycaspase9[16].Baxisaproteinthatforms
a homodimer or heterodimers with Bcl-2, and apoptosis
depends on the ratio of these two proteins because it is
promoted by Bax and inhibited by Bax/Bcl-2 heterodimers
[17]. The extrinsic pathway is regulated by proteins such
as Fas (also called Apo-1 or CD95), and it involves speciﬁc
caspases, in particular caspase 8, a connecting ligand binding
at the cell surface to apoptotic induction [18].
Bax positive immunostaining appeared in the cells of all
layers of varicose veins and in Group II a strong staining
of Bax was seen in the adventitia, the media and the
subendothelial layer, while in the endothelium staining was
moderate (Figure 3). The most intensive Bax staining was
found in the media in Group II (Figure 4(a)). In Group I and
GroupIIIBaxstainingintensitywasequallylowerinalllayers
of the vein wall (Figure 4(b)) as compared to Group II, only
expression of Bax in the adventitia stayed almost at the same
level in all groups (Figure 3).
The count of apoptotic EC and SMC as detected by the
TUNEL method in varicose veins increased in Groups II and
III with the advancing age of patients. As shown in Figure 5,
in Group II and especially in Group III the percentage
of apoptotic EC and SMC was increased. Representative
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Figure 1: Changes of NF-kappaB expression in the wall of varicose
veins. Statistically signiﬁcant diﬀerences in the media—Group II
versus Group III P<0.05, in the adventitia—Group I versus Group
II P<0.05.
Group III an increase of apoptotic cells was also seen in vasa
vasorum.
4. Discussion
In this study, as in our earlier investigation [24], we found
a trend of the number of apoptotic cells to increase in the
walls of varicose veins along with the advancing age. An
increase of apoptotic SMCs and, in particular, apoptotic
ECs was seen in older age groups (Figure 5). Still, the
advancing age can itself be a factor that sensitizes cells to
apoptosis. When assaying human umbilical vein endothelial
cells, Wagner and coauthors [25] have shown an age-related
increase in apoptosis, while Hoﬀmann and coauthors [26]
demonstrated that aging increased the sensitivity of cells
to apoptosis. Thus, in the group of older patients of our
study, the increased number of apoptotic cells seen in the
wall of varicose veins may be the result of two processes, an
increased sensitivity to apoptosis induced by aging and the
long-lasting course of the disease leading the pathology to a














Figure 2: Expression of the NF-kappaB in the endothelium (E), subendothelial layer (SubE), and media (M). Group II (a) and Group III
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Adventitia
Figure 3: Changes of Bax expression in the walls of varicose veins.
Statistically signiﬁcant diﬀerences in the endothelium; Group II
versus Group III P<0.01, in the subendothelial layer; Group I
versus Group II P<0.05 and Group II versus Group III P<0.05,
in the media-Group I versus Group II P<0.01 and Group II versus
Group III P<0.05.
on apoptosis in the varicose vein walls in which diﬀerent age
groups of patients have been compared. Urbanek and co-
authors [14] have reported an increase of apoptotic SMCs
in the varicose veins of subjects under 50 years of age,
but not in older patients, which circumstance leads them
to the speculation that apoptosis plays a role in the initial
stage of the pathology but not in the advanced stages of the
disease. Nevertheless, dysregulated apoptosis in the walls of
varicose veins is attributed to the pathogenesis of the disease
[1]. If Bujan and co-authors [13] have found an increase
of apoptotic SMCs in the varicose vein wall, then others
[10–12, 14]h a v er e p o r t e dar e d u c e dn u m b e ro fa p o p t o t i c
cells in varicose veins. Our preliminary data also allow us
to speculate that the apoptosis of SMCs in non-varicose
veins is higher than that in varicose veins, while in the case
of apoptotic ECs the situation is likely the opposite; that
is, apoptosis of ECs in nonvaricose veins may be lower.
One of the pathogenetic mechanisms of dysregulated SMC
apoptosis in the varicose vein wall may be connected with
SMCs dediﬀerentiation from a contractile phenotype to a
secretory one. Several investigations [27–29]h a v ef o u n d
that ﬁbrotic degeneration with the disruption of the elastic
network seen in varicose veins may be related to the
accumulation of secretory SMCs. Increased ECs apoptosis
seen in older age groups of our investigation may result in
a partial loss of endothelial lining that we have also described
in our previous studies [5]. Applying transmission electron
microscopy, degeneration and a loss of ECs in varicose veins
have also been reported by Wali and Eid [6]. Impairment of
the endothelial layer may in turn activate signaling cascades
that induce SMC migration to the subintima and cause
their proliferation and a synthesis of large quantities of the
extracellular matrix [30, 31].
In apoptotic signaling in varicose veins, the intrinsic but
nottheextrinsicpathwayhasbeenfoundtobeinvolved.Both
Ducasse with co-authors [10] and Lee with co-authors [8]
have reported the downregulation of proapoptotic proteins
Bax or Bcl-2 and caspase 9 in the walls of varicose veins
showing the involvement of the intrinsic pathway, while no
changes were detected in Fas and caspase 8 characterizing
the extrinsic signaling pathway. Also Ascher and co-authors
[12] have shown that the entry of SMCs into the apoptotic
pathway is regulated by Bax, which is downregulated in
varicose veins in comparison with healthy veins. In our study
we were also able to follow changes in the Bax expression
in the layers of varicose veins of diﬀerent age groups. An
increase in the Bax expression in Group II (ages of patients
between 36 and 50 years) was found in the intima (including
the endothelium), in the media, but not in the adventitia as
compared to both younger and older patient groups, that
is, Groups I and III (Figure 3). These results support the
hypothesis that there may be a gradual increase of apoptosis
during the earlier stages of the pathology, while in advanced
stages the role of apoptosis may be less important. This
speculative mechanism is supposed to exist by Urbanek and
co-authors [14], who have found an increased apoptotic
















Figure 4: Expression of the Bax in the endothelium (E), subendothelial layer (SubE), and media (M). Group II (a) and Group III (b). (c)















Figure 5: Changes in the percentage of apoptotic endothelial cells
and smooth muscle cells. Statistically signiﬁcant diﬀerences in the
percentage of apoptotic endothelial cells were between Group I
versus Group II P<0.05 and Group I versus Group III P<0.01.
varicose veins of patients younger than 50 years, but not in
older subjects. Relatively higher EC and SMC apoptosis and
lower levels of Bax in the intima and media of varicose veins
of patients over 50 years of age (Group III) documented in
our study may be explained by shifts in the sensitivity of cells
to apoptosis caused by aging or by changed signaling during
the advanced stage of the pathology; for example, instead
of the intrinsic pathway, the extrinsic apoptotic signaling
cascade is executed. Furthermore, the apoptosis of ECs and
SMCs in the walls of varicose veins may be diﬀerently
regulated or these cells react diﬀerently to apoptotic stimuli.
Sata and co-authors [32]h a v er e p o r t e dad i ﬀerent sensitivity
of ECs and SMCs to Fas-mediated apoptosis. In their in vitro
experiment after stimulation with tumor necrosis factor α
(TNF-α) or interferon-gamma (IFN-γ), the upregulation of
Fas was seen in ECs but not in vascular SMCs. Similarly, in
our study of elderly patients in Group III, the apoptosis of
ECs tends to increase, while the apoptosis of SMCs remained
on the same level as in Group II (Figure 5).
When comparing the expression of NF-kappaB (p105/
p50) in the walls of varicose veins of patients of three age
groups of our study, the lowest levels were noted in Group
II. Low NF-kappaB expression was seen in all layers; it
was the most remarkable in the media and less obvious
in the endothelium, thus, again supporting the notion of
diﬀerential regulation of SMCs and ECs. Both in Groups I
and III higher NF-kappaB levels were found in the varicose
vein wall (Figure 1). As seen from our investigations, a
decrease in the NF-kappaB level in Group II was associated
with an increase in the Bax expression in the same group
(Figures 1 and 3). NF-kappaB, beside its pivotal roles in
immune and inﬂammatory responses, is considered to be
a critical player in the control of the apoptotic response
to a variety of stimuli [21]. NF-kappaB is most commonly
involved in the suppression of apoptosis by transactivating
the expression of antiapoptotic genes. It has also been
shown that NF-kappaB can inhibit the expression of Bax.
Bentires-Alj and co-authors [33] have demonstrated that
NF-kappaB regulates the Bax gene expression through the
indirect pathway. In our study, when comparing groups of
young and older patients, that is, Group I versus Group II,
an increase in the apoptotic EC and SMC count was noticed
in Group II together with a higher level of proapoptotic Bax
and a reduced level of antiapoptotic NF-kappaB (p105/p50).
The described changes were particularly evident in the
medial layer of varicose veins. In patients of Group III
the apoptosis of EC and SMC stayed high, though in the
vein wall the expression of Bax decreased and p105/p50
increased to the level seen in Group I. This discrepancy can
beexplainedbytheprocessofaging,whichmaysensitizecells
to apoptosis, with other signaling cascades activated. It can
also be speculated that the p105/p50 increase in the varicose
veins of older patients of Group III with an advanced stage
of the disease may be related to the augmentation of the
inﬂammatory component in the walls of varicose veins as
the NF-kappaB signaling cascade may be activated both by
inﬂammation and the aging process [34, 35].
5. Conclusion
In conclusion, our study demonstrated that in varicose veins
the apoptosis of ECs and SMCs increases with the advancing















Figure 6: Apoptotic smooth muscle cells (SMCs), and endothelial cells (ECs). Group II (a) and Group III (b). (c) and (d) represent negative
controls (Group II).
with presumably earlier stages of the pathology, increasing
apoptotic activity can be associated with a higher level of
Baxanda lower level of NF-kappaB (p105/p50). This process
w a ss e e ni nt h ed i ﬀerent layers of the varicose vein wall
with the most prominent manifestation in the media. In
the third age group of patients with more advanced stage of
the disease, higher EC and SMC apoptosis was seen despite
lowering the level of Bax and increasing, level of p105/p50
assuming that other signaling cascades may be involved in
apoptotic regulation. The impact of the aging process and
the progression of inﬂammation on the NF-kappaB cascade
and apoptotic regulation cannot be ruled out. Additional
studies with implication of other NF-kappaB subunits and
members of Bcl-2 family are essentially needed to draw more
substantial conclusions.
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